PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Columbia Center for Translational Immunology (CCTI), Division of Hematology/ Oncology, Columbia University Medical Center, New York, New York, USA.\', \'Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, USA; Department of Medicine, Blood and Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York, New York, USA.\', \'Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, USA.\', \'Department of Medicine, Division of Infectious Disease, Columbia University College of Physicians and Surgeons, New York, New York, USA.\', \'Columbia Center for Translational Immunology (CCTI), Division of Hematology/ Oncology, Columbia University Medical Center, New York, New York, USA; Department of Medicine, Blood and Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York, New York, USA.\', \'Columbia Center for Translational Immunology (CCTI), Division of Hematology/ Oncology, Columbia University Medical Center, New York, New York, USA; Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States.. Electronic address: pjm2170@cumc.columbia.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1465-3249(21)00685-X10.1016/j.jcyt.2021.05.005
?:hasPublicationType
?:journal
  • Cytotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34183244
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.144
?:rankingScore_hIndex
  • 72
is ?:relation_isRelatedTo_publication of
?:title
  • Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all